Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients
Official title: Enhanced Recovery Pathway for Chronic Subdural Hematoma
Run by Universitaire Ziekenhuizen KU Leuven · NCT07421453 · Data updated 2026-11-12
This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Status | Recruiting |
| Started | December 23, 2024 |
| Main results expected | September 30, 2027 |
| Study ends | July 31, 2028 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT07421453 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a chronic subdural hematoma requiring burr-hole drainage who can provide informed consent (or have a legally acceptable representative) are the intended participants.
✕Probably not a fit
Patients with significant underlying cerebral lesions (for example tumors or vascular lesions) or with prior treatment of the same-sided chronic subdural hematoma are excluded and thus unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational project implements a standardized enhanced recovery protocol (ERP) for patients undergoing burr-hole drainage of chronic subdural hematoma and compares outcomes to a historical cohort. The ERP includes decision guidelines (surgery versus middle meningeal artery embolization), specific surgical technique modifications, and uniform postoperative care pathways. Primary safety outcome is hematoma recurrence at six months, with additional measures of complication rates and 30-day outcomes. Eligible adults treated at the center without major underlying cerebral lesions are enrolled and outcomes are tracked prospectively.
Why it matters
Potential benefit: If successful, the protocol could lower recurrence and complication rates and streamline recovery after burr-hole drainage for chronic subdural hematoma.
How similar studies have gone: Enhanced recovery protocols have improved outcomes in other surgical fields and smaller series suggest benefits for cSDH, but combining decision algorithms, surgical modifications, and embolization pathways in a single ERP is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Existence of a chronic subdural hematoma requiring burr-hole drainage * Written informed consent to participate in the study must be obtained from the subject. If the subject is not capable of self-consent, all efforts will be made to locate a legally acceptable representative to act on behalf of the subject. When the patient is considered capable to consent but physically unable to sign an informed consent form and a representative is not available an impartial witness can attend the informed consent process. Exclusion Criteria: * Existence of an important underlying cerebral lesion (e.g. a vascular lesion, tumor) * History of treatment (surgical or by middle meningeal artery embolization) of a same sided cSDH
Where it's running
-
University Hospitals Leuven
Leuven, Belgium Recruiting
Study contacts
- Principal investigator: Thomas Decramer, MD, PhD — Universitaire Ziekenhuizen KU Leuven
- Study coordinator: Siebe Orolé, Medical degree
- Email: neurochirurgie@uzleuven.be
- Phone: +32 16 34 42 90
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma
This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
Coil embolization for unilateral vs bilateral chronic subdural hematomas
This trial tests whether unilateral or bilateral coil-based embolization of the middle meningeal artery helps people with chronic subdural hematoma.
-
Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma
A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.
-
Seeing if antibiotics given after surgery reduce recurrence of chronic subdural hematoma
This trial will test whether a short course of amoxicillin‑clavulanate given after surgery can lower the chance of chronic subdural hematoma coming back in adults.
-
Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural Haematoma
This study tests whether safely coagulating small branches of the middle meningeal artery during burr-hole drainage can reduce recurrence of chronic subdural haematoma in adults receiving standard surgical care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.